Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Janssen patents free fatty acid receptor 1 agonists

Feb. 27, 2017

EMA committee supports conditional marketing approval for Shire's Natpar

Feb. 27, 2017

JCR plans to begin development of JR-162 to treat Pompe disease

Feb. 27, 2017

Caladrius Biosciences receives grant for development of cell therapy CLBS-03

Feb. 24, 2017

UAB developing peptide with potential for homozygous familial hypercholesterolemia

Feb. 24, 2017

Janssen Pharmaceutica divulges novel FFA1 receptor agonists

Feb. 24, 2017

Phase I results for Diamyd vaccine presented for type 1 diabetes

Feb. 24, 2017

ImmusanT completes phase Ib study of Nexvax2

Feb. 23, 2017

EMA grants orphan drug designation to LYS-GM101 for the treatment of GM1 gangliosidosis

Feb. 22, 2017

European Commission approves new single-dose delivery option for Repatha

Feb. 22, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026